Enzomenib

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameEnzomenib
Drug Alias NameDSP-5336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin inhibitorsProtein interaction domain and motifs inhibitors
TargetsMenin
Therapy Area/IndicationsMyelodysplastic SyndromesHematologic NeoplasmsMultiple Myeloma +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesHematologic NeoplasmsMultiple Myeloma +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A